The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin ß1 and CXCL12

Cancer Research

Volumn 69, Issue 7, 2009, Pages 3221-3227

  Hernandez, Lorena ^a   Smirnova, Tatiana ^a   Kedrin, Dmitriy ^a   Wyckoff, Jeffrey ^a   Zhu, Liyin ^a   Stanley, E Richard ^a   Cox, Dianne ^a   Müller, William J ^b   Pollard, Jeffrey W ^a   Rooijen, Nico Van ^c   Segall, Jeffrey E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; EPIDERMAL GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR BETA1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HEREGULIN BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN ERB3; CELL STRAIN MTLN3; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MACROPHAGE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CHEMOKINE CXCL12; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEUREGULIN-1; RATS; RECEPTOR, ERBB-3; SIGNAL TRANSDUCTION;

EID: 66149134501     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2871     Document Type: Article

References (38)

1. Steeg PS Tumor metastasis: mechanistic insights and. clinical challenges. Nat Med 2006:12:895-904.
2. Wyckoff JB, Segall JE, Condeells JS The collection of the motile population of cells from a living tumor. Cancer Res 2000;60:5401-5404
3. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004;64:7022-7029
4. Goswami S, Sahai E, Wyckoff JB, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-5283
5. Bingle L, Brown NJ, Lewis CE The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254-265
6. Scholl SM, Pallud C, Beuvon F, et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl. Cancer Inst 1994;86:120-126
7. Lin EY, Gouon-Evans V, Nguyen AV Pollard JW The macrophage growth factor CSF-I. in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002;7:147-162
8. Scholl SM, Lldereau R, de la Rochefordiere A, et al. Circulating levels of the macrophage colony stimulating factor CSF-I in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res Treat 1996:39: 275-283
9. Lin EY, Nguyen AV Russell RG, Pollard JW Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-740
10. Wyckoff JB, Wang Y, Lin EY, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007;67:2649-2656
11. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in. breast cancer metastasis. Nature 2001;410:50-56
12. Kato M, Kitayama J, Kazama S, Nagawa H Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003;5:R1.44-50.
13. Breuleux M Role of heregulin in human cancer. Cell Mol life Sci 2007;64:2358-2377
14. Teal MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 2003; 22:761-768
15. Spencer KS, Graus-Porta D, Leng J, Hynes NE, Klemke RL ErbB2 is necessary for Induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 2000;148:385-397
16. Xue C, Liang F, Mahmood R, et al. ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 2006;66:1418-1426
17. Siegel PM, Ryan ED, Cardiff RD, Muller WJ Elevated expression, of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 1999;18:2149-2164
18. Guy CT, Cardiff RD, Muller WJ Induction of mammary tumors by expression of Polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. MoI Cell Biol 1992;12:954-961
19. Sudo T, Nishikawa S, Ogawa M, et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995;11:2469-2476
20. van Rooijen N, van Kesteren-Hendrlkx E "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol 2003;373:3-16.
21. Austyn JM, Gordon S F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981:11:805-815
22. Matulka LA, Triple AA, Wagner KU. Parity-induced mammary epithelial, cells are multipotent and express cell surface markers associated with stem ceUs. Dev Biol 2007;303:29-44.
23. Wakeling AE, Guy SP, Woodburn. JR, et al. ZD1.839 (Iressa): an oraUy active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002;62:5749-54.
24. Hatse S, Prlncen K, Bridger G, De Clercq E, Schols D. Chemokine receptor inhibition by AMD3.100 Is strictly confined to CXCR4. FEBS Lett 2002;527:255-62.
25. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006;107:1761-7.
26. Rang H, Watkins G, Parr C, Douglas-Jones A, Maneei RE, Jiang WG. Stromal cell derived factor-1: its influence on Invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival, in human breast cancer. Breast Cancer Res 2005:7:R402-10.
27. Dunn M, Sinha P1 Campbell R1 et al. Co-expression of neuregullns I1 2, 3 and 4 In human breast cancer. J Pathol 2004;203:672-80.
28. Atlas E, Cardillo M, Mehml I, Zahedkargaran H, Tang C, Lupu R. HereguUn is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. MoI Cancer Res 2003:1:165-75.
29. Stove C, Bracke M. Roles for neuregullns in human cancer. Clin Exp Metastasis 2004;21.:665-84.
30. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in Invasive human, breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. CeU 2005:121:335-48.
31. Allinen M, Beroukhim. R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
32. Iivanainen E, Paatero I, Heikkinen SM, et al. Intraand extracellular signaling by endothelial neuregulin-1. Exp Cell Res 2007;313:2896-909.
33. Lemmens K, Segers VF, Demolder M, De Keulenaer GW. Role of neuregulin-l/ErbB2 signaling in endothelium-cardlomyocyte cross-talk. J Biol. Chem 2006;281:19469-77.
34. Cote GM, Miller TA, Lebrasseur NK, Kuramochl Y, Sawyer DB. NeureguUn-la and ß isoform expression in cardiac microvascular endothelial ceUs and function in cardiac myocytes in vitra. Exp Cell Res 2005;31.1:135-46.
35. Liang Z, Wu H, Reddy S, et al. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun. 2007;363:542-6.
36. Lichtner RB, Wiedemuth M1 Kittmann A, Ullrich A, Schirrmacher V, Khazaie K. Ligand-induced activation of epidermal growth factor receptor in intact rat mammary adenocarcinoma cells without detectable receptor phosphorylation. J Biol Chem 1992;267:11872-80.
37. Fltzpatrlck SL, LaChance MP, Schultz GS. Characterization of epidermal growth factor receptor and action on. human breast cancer cells in culture. Cancer Res 1984;44:3442-7.
38. Fllmus J, Pollak MN, Cailleau H Bulck RN. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 1985;128:898-905.